These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8005184

  • 21. The metabolism of synthetic leukotriene B4 in synovial fluid and whole human blood.
    Forrest MJ, Burton D, Brooks PM.
    Prostaglandins; 1987 Sep; 34(3):433-43. PubMed ID: 2829280
    [Abstract] [Full Text] [Related]

  • 22. PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats.
    Rocha FA, Andrade LE, Russo M, Jancar S.
    J Lipid Mediat Cell Signal; 1997 May; 16(1):1-10. PubMed ID: 9101418
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G, Rordorf C, Reynolds C, Kalbag J, Looby M, Milosavljev S, Weaver M, Huff JP, Ruff DA.
    Clin Pharmacokinet; 2004 May; 43(7):467-78. PubMed ID: 15139795
    [Abstract] [Full Text] [Related]

  • 24. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG, Francis HW, Roberts MS.
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [Abstract] [Full Text] [Related]

  • 25. Development of enzyme-linked immunosorbent assays for measurement of leukotrienes and prostaglandins.
    Miller DK, Sadowski S, DeSousa D, Maycock AL, Lombardo DL, Young RN, Hayes EC.
    J Immunol Methods; 1985 Aug 02; 81(2):169-85. PubMed ID: 2991387
    [Abstract] [Full Text] [Related]

  • 26. The contribution of synovial fluid lipoproteins to the chronic synovitis of rheumatoid arthritis.
    Prete PE, Gurakar-Osborne A.
    Prostaglandins; 1997 Oct 02; 54(4):689-98. PubMed ID: 9440132
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment.
    Daymond TJ, Rowell FJ.
    Drugs; 1988 Oct 02; 35 Suppl 1():4-8. PubMed ID: 3162870
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of clodronate on synovial fluid levels of some inflammatory mediators, after intra-articular administration to patients with synovitis secondary to knee osteoarthritis.
    Cocco R, Tofi C, Fioravanti A, Nerucci F, Nannipieri F, Zampieri A, Rosini S, Marcolongo R.
    Boll Soc Ital Biol Sper; 1999 Oct 02; 75(11-12):71-6. PubMed ID: 11433681
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Naproxen concentrations in serum, synovial fluid, and synovium.
    Jalava S, Saarimaa H, Anttila M, Sundquist H.
    Scand J Rheumatol; 1977 Oct 02; 6(3):155-7. PubMed ID: 929122
    [Abstract] [Full Text] [Related]

  • 39. Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood.
    Salisbury C, Sharif M.
    Ann Rheum Dis; 1997 Sep 02; 56(9):558-61. PubMed ID: 9370881
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.